03:46 PM EST - Aeterna Zentaris Inc. : announced that it entered into a collaboration agreement with Ventana Medical Systems, Inc., a member of the Roche Group, to develop a companion diagnostic for the immunohistochemical determination of luteinizing hormone-releasing hormone (LHRH) receptor expression, for the Company's doxorubicin LHRH targeted conjugate compound, AEZS-108. Aeterna Zentaris Inc.
shares T.AEZ are trading up $0.02 at $1.60.
